Tech Company Financing Transactions
Engrail Therapeutics Funding Round
Engrail Therapeutics secured a $157 million Series B funding round on 3/19/2024. Investors included F-Prime Capital, Forbion Capital Partners and Norwest Venture Partners.
Transaction Overview
F-Prime Capital (Lead Investor)
Forbion Capital Partners (Lead Investor)
Norwest Venture Partners (Lead Investor)
Company Information
San Diego, CA 92130
USA
Management Team
Browse more venture capital transactions:
Prev: 3/19/2024: Ingrid venture capital transaction
Next: 3/19/2024: Keyring Network venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs